We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$42.6B
AUM Growth
-$927M
(-2.1%)
Cap. Flow
-$4.42B
Cap. Flow
% of AUM
-10.38%
Top 10 Holdings %
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Sana Biotechnology
SANA
$980M
| $898K | ﹤0.01% |
89,800
+15,042
| +20% | +$113K |
|
1977
Costamare
CMRE
$1.77B
| $897K | ﹤0.01% |
79,062
+8,519
| +12% | +$94.4K |
|
1978
Benchmark Electronics
BHE
$2.96B
| $897K | ﹤0.01% |
29,874
-87,315
| -75% | -$2.52M |
|
1979
Aura Biosciences
AURA
$826M
| $894K | ﹤0.01% |
113,889
+71,502
| +169% | +$593K |
|
|
OPI
1980
DELISTED
Office Properties Income Trust
OPI
| $894K | ﹤0.01% |
438,121
+144,601
| +49% | +$497K |
|
1981
Vishay Intertechnology
VSH
$5.43B
| $894K | ﹤0.01% |
39,404
-22,401
| -36% | -$499K |
|
1982
Univest Financial
UVSP
$1.18B
| $892K | ﹤0.01% |
42,860
+2,677
| +7% | +$54.4K |
|
1983
Rimini Street
RMNI
$471M
| $892K | ﹤0.01% |
273,474
+80,801
| +42% | +$258K |
|
|
CNTA
1984
DELISTED
Centessa Pharmaceuticals
CNTA
| $890K | ﹤0.01% |
78,781
+62,281
| +377% | +$590K |
|
1985
The Honest Company
HNST
$586M
| $890K | ﹤0.01% |
219,762
+200,810
| +1,060% | +$677K |
|
1986
ANI Pharmaceuticals
ANIP
$1.78B
| $888K | ﹤0.01% |
12,845
-13,905
| -52% | -$839K |
|
1987
American States Water
AWR
$3.46B
| $887K | ﹤0.01% |
12,278
-24,256
| -66% | -$1.81M |
|
1988
KNOT Offshore Partners
KNOP
$366M
| $880K | ﹤0.01% |
170,573
-28,318
| -14% | -$159K |
|
1989
Treace Medical Concepts
TMCI
$309M
| $880K | ﹤0.01% |
+67,412
| New | +$899K |
|
1990
Brown-Forman Class B
BF.B
$13.1B
| $878K | ﹤0.01% |
17,013
+11,113
| +188% | +$619K |
|
1991
iShares US Oil Equipment & Services ETF
IEZ
$364M
| $877K | ﹤0.01% |
37,100
-54,400
| -59% | -$1.16M |
|
|
CMRC
1992
Commerce.com Inc Series 1
CMRC
$184M
| $873K | ﹤0.01% |
126,725
-211,223
| -63% | -$1.69M |
|
1993
Scorpio Tankers
STNG
$3.81B
| $873K | ﹤0.01% |
12,203
-202,625
| -94% | -$13.7M |
|
1994
Medallion Financial
MFIN
$250M
| $872K | ﹤0.01% |
110,294
+12,436
| +13% | +$112K |
|
1995
Ubiquiti
UI
$34.3B
| $872K | ﹤0.01% |
+7,526
| New | +$923K |
|
1996
Compass
COMP
$9.66B
| $872K | ﹤0.01% |
242,167
-33,833
| -12% | -$120K |
|
1997
Bank of Marin Bancorp
BMRC
$459M
| $871K | ﹤0.01% |
51,962
+31,135
| +149% | +$569K |
|
1998
iShares MSCI Emerging Markets ETF
EEM
$30B
| $870K | ﹤0.01% |
+21,179
| New | +$843K |
|
1999
Expensify
EXFY
$245M
| $870K | ﹤0.01% |
472,634
+37,013
| +8% | +$70.3K |
|
|
TSE
2000
DELISTED
Trinseo
TSE
| $869K | ﹤0.01% |
229,843
-8,646
| -4% | -$46.1K |
|
Similar funds
VAM
Two Sigma Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Two Sigma Investments held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Two Sigma Investments withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Investments opened a new position in Pfizer worth $234M.
- Two Sigma Investments's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- Two Sigma Investments added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- Two Sigma Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- Two Sigma Investments fully exited Rivian in Q1 2024, selling an estimated $158M.
- Two Sigma Investments's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- Two Sigma Investments opened 408 new positions and closed 532 in Q1 2024.
- Two Sigma Investments's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.